Intuitive Surgical Sees Steady Increase In Robotic Surgery Adoption
December 27, 2023
☀️Trending News
Intuitive Surgical ($NASDAQ:ISRG), a leader in developing and manufacturing robotic surgical systems and instruments, has seen a steady increase in adoption of its robotic surgery procedures over the years. Robotic surgery offers many advantages to patients, such as decreased pain and trauma, shorter hospital stays, and faster recovery times. The success of Intuitive Surgical’s innovations has led to the development of a broad range of products for use in a variety of surgical specialties.
Intuitive Surgical’s stock has also seen an impressive rise over the last decade. With a bright outlook for the future of robotic surgery, Intuitive Surgical is poised to continue its steady growth in the coming years.
Price History
On Tuesday, INTUITIVE SURGICAL stock saw a steady increase in price, opening at $336.9 and closing at $337.4, up by 0.3% from the previous closing price of $336.3. This marks an overall upward trend in the company’s stock. With the increasing acceptance of robotics in surgical operations, INTUITIVE SURGICAL is set to profit.
Furthermore, the company’s research into robotics has allowed them to develop better and more efficient solutions for precision-based medical operations. This has further increased their foothold in the medical field and has been reflected in their stock price. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Intuitive Surgical. More…
| Total Revenues | Net Income | Net Margin |
| 6.85k | 1.52k | 22.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Intuitive Surgical. More…
| Operations | Investing | Financing |
| 2.02k | 1.26k | -1.22k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Intuitive Surgical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 14.71k | 2.09k | 35.61 |
Key Ratios Snapshot
Some of the financial key ratios for Intuitive Surgical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 16.7% | 17.9% | 24.7% |
| FCF Margin | ROE | ROA |
| 18.3% | 8.6% | 7.2% |
Analysis
At GoodWhale, we have conducted a financial analysis of INTUITIVE SURGICAL and are pleased to share our findings. According to our Star Chart analysis, INTUITIVE SURGICAL has a high health score of 10/10 when it comes to its cashflows and debt, meaning it is capable of sustaining future operations in times of crisis. Looking at the other categories, INTUITIVE SURGICAL is strong in assets, growth, and profitability, but weaker on dividend. We have classified INTUITIVE SURGICAL as a ‘gorilla’, a type of company that has achieved stable and high revenue or earning growth due to its strong competitive advantage. Given these results, investors interested in companies that have long-term growth potential would be most suited to INTUITIVE SURGICAL. Those seeking companies with strong dividend yields may be less interested. We hope our analysis has helped provide clarity to potential investors. More…
Peers
The company’s da Vinci surgical system consists of a surgeon’s console, a patient-side cart and a vision system. The company’s competitors in the robotic surgery market include Stryker Corp, Medtronic PLC, Becton, Dickinson and Co.
– Stryker Corp ($NYSE:SYK)
With a market capitalization of $84.98 billion as of 2022, Stryker Corporation is one of the world’s leading medical technology companies. Headquartered in Kalamazoo, Michigan, the company offers a broad range of products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient care and quality of life. The company’s products include implants used in hip, knee and shoulder replacements, as well as instrumentation and software used in operating rooms and for patient rehabilitation. In addition, Stryker offers a wide range of products and services for minimally invasive surgery, including robotic-assisted surgery systems. The company’s return on equity was 10.79% as of 2022.
– Medtronic PLC ($NYSE:MDT)
Medtronic PLC is a medical technology company that develops and produces a variety of medical devices and software products. The company has a market capitalization of 112.31 billion as of 2022 and a return on equity of 7.49%. Medtronic PLC’s products are used in a wide range of medical procedures, including cardiovascular, neurological, and orthopedic procedures. The company’s products are sold in over 150 countries around the world.
– Becton, Dickinson and Co ($NYSE:BDX)
Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, laboratory equipment, and diagnostic products. The company has a market cap of 64.37B as of 2022 and a return on equity of 6.42%. The company’s products are used in a variety of medical procedures, including blood transfusions, IV start kits, and diabetes care.
Summary
Intuitive Surgical is a medical technology company that has seen consistent growth in its robotic surgical systems. Revenue growth has been driven primarily by increased system sales and the growing utilization of instruments and accessories. The company’s competitive advantages include product innovation, customer service, and the strength of its surgeons/doctors network.
Its strategy focuses on expanding the use of its systems in existing applications, introducing new products, and expanding into new geographic markets. Intuitive Surgical is well-positioned to continue to grow its revenue for the foreseeable future.
Related Posts
Recent Posts
